Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland — a qualitative study

Table 1 Participants’ characteristics (n = 17)

		Number	Percentage
Gender	Male	7	41%
Gender	Female	10	59%
Age at F-PSP’s inclusion	< 30 years	4	24%
	30–50 years	11	65%
	> 50 years	2	12%
Previous experience in MS treatment	Naïve^a	11	65%
Previous experience in MS treatment	Experimented	6	35%
F-PSP’s duration^b	< 1 year	3	18%
F-PSP’s duration^b	≥ 1 year	14	82%
F-PSP’s setting	Pharmacy of Unisanté	13	76%
F-PSP’s setting	Other pharmacy	4	24%

F-PSP: Fingolimod Patient Support Program
^a patients who had never taken any MS treatment before the initiation of the F-PSP
^b at the beginning of the qualitative study (March 3, 2017)

ISSN: 1472-6963